Receives EIR from U.S. FDA for its Somerset Facility - Lupin Ltd

Code BSE: 500257 NSE: $LUPIN Lupin Receives EIR from U.S. FDA for its Somerset Facility with VAI Classification Nilesh Gupta, Managing Director, Lupin, said, “We are pleased to receive the EIR with a VAI classification from the U.S. FDA for our Somerset facility. This outcome reflects our unwavering commitment to quality, compliance, and operational excellence, and reinforces our dedication to manufacturing highquality medicines that patients around the world can trust.”